The second U.s. company receives stem cells go-ahead (Reuters)
Maggie Fox, health and Science Editor Maggie Fox, health and Science Editor – Mon Nov 22, 2: 21 pm ET, WASHINGTON (Reuters)-the u.s. food and Drug Administration has approved a second human trial of human embryonic stem cell--one testing cells in humans that awful gradually form, the company said on Monday. Massachusetts-based enhanced cell Technology, said it would start testing 12 patients with macular dystrophy Stargardt's stem cell treatment based on it. Human embryonic stem cells shall be approved by the FDA, the second is the subject of this year. Last month, the first patient enrolled in Geron Corp. using it; in people with spinal cords crushed in the investigation. "It is exciting--vindication. All this work really came through, "said Dr. Robert Lanza, Chief Medical Officer of the company, which has struggled to stay solvent gambled controversial in the cells. Stem cells are the cells in the body of the master, all other cells in the source. Supporters of the use ...